Management Issues in Conjunctival Tumours: Ocular Surface Squamous Neoplasia

Abstract

Ocular surface squamous neoplasia is the most common tumour of the ocular surface. It is a spectrum of disease from intraepithelial dysplasia to invasive squamous cell carcinoma. Recent years have seen an increase in the use of topical chemotherapeutic agents to treat this condition, often as primary treatment without full-thickness biopsy. This practical approach provides a critical appraisal of the evidence base with the goal being to aid the clinician in the management of these patients.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Shields CL, Demirci H, Karatza E, Shields JA. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology. 2004;111(9):1747–54. https://doi.org/10.1016/j.ophtha.2004.02.013.

    Article  PubMed  Google Scholar 

  2. 2.

    Shields CL, Alset AE, Boal NS, et al. Conjunctival tumors in 5002 cases. Comparative analysis of benign versus malignant counterparts. The 2016 James D. Allen Lecture. Am J Ophthalmol. 2017;173:106–33. https://doi.org/10.1016/j.ajo.2016.09.034.

    Article  PubMed  Google Scholar 

  3. 3.

    Kiire CA, Stewart RMK, Srinivasan S, Heimann H, Kaye SB, Dhillon B. A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom. Eye Lond Engl. 2019;33(2):283–94. https://doi.org/10.1038/s41433-018-0217-x.

    CAS  Article  Google Scholar 

  4. 4.

    Honavar SG, Manjandavida FP. Tumors of the ocular surface: a review. Indian J Ophthalmol. 2015;63(3):187–203. https://doi.org/10.4103/0301-4738.156912.

    Article  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Surv Ophthalmol. 2004;49(1):3–24.

    Article  Google Scholar 

  6. 6.

    Sayed-Ahmed IO, Palioura S, Galor A, Karp CL. Diagnosis and medical management of ocular surface squamous neoplasia. Expert Rev Ophthalmol. 2017;12(1):11–9. https://doi.org/10.1080/17469899.2017.1263567.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39(6):429–50.

    CAS  Article  Google Scholar 

  8. 8.

    Edge SE, Byrd DR, Carducci M, Compton CC, editors. AJCC ophthalmic oncology task force. Carcinoma of the conjunctiva. In: AJC cancer staging manual. 7th edn. New York: Springer; 2009, pp 531–8.

  9. 9.

    Li AS, Shih CY, Rosen L, Steiner A, Milman T, Udell IJ. Recurrence of ocular surface squamous neoplasia treated with excisional biopsy and cryotherapy. Am J Ophthalmol. 2015;160(2):213–219.e1. https://doi.org/10.1016/j.ajo.2015.04.027.

    Article  PubMed  Google Scholar 

  10. 10.

    Tabin G, Levin S, Snibson G, Loughnan M, Taylor H. Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. Ophthalmology. 1997;104(3):485–92.

    CAS  Article  Google Scholar 

  11. 11.

    Galor A, Karp CL, Oellers P, et al. Predictors of ocular surface squamous neoplasia recurrence after excisional surgery. Ophthalmology. 2012;119(10):1974–81. https://doi.org/10.1016/j.ophtha.2012.04.022.

    Article  PubMed  PubMed Central  Google Scholar 

  12. 12.

    Nanji AA, Moon CS, Galor A, Sein J, Oellers P, Karp CL. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. Ophthalmology. 2014;121(5):994–1000. https://doi.org/10.1016/j.ophtha.2013.11.017.

    Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Sturges A, Butt AL, Lai JE, Chodosh J. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Ophthalmology. 2008;115(8):1297–302.e1. https://doi.org/10.1016/j.ophtha.2008.01.006.

    Article  PubMed  Google Scholar 

  14. 14.

    Schechter BA, Koreishi AF, Karp CL, Feuer W. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. Ophthalmology. 2008;115(8):1291–6.e1. https://doi.org/10.1016/j.ophtha.2007.10.039.

    Article  PubMed  Google Scholar 

  15. 15.

    Boehm MD, Huang AJW. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b. Ophthalmology. 2004;111(9):1755–61. https://doi.org/10.1016/j.ophtha.2004.01.034.

    Article  PubMed  Google Scholar 

  16. 16.

    Venkateswaran N, Mercado C, Galor A, Karp CL. Comparison of topical 5-fluorouracil and interferon alfa-2b as primary treatment modalities for ocular surface squamous neoplasia. Am J Ophthalmol. 2019;199:216–22. https://doi.org/10.1016/j.ajo.2018.11.007.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Karp CL, Galor A, Chhabra S, Barnes SD, Alfonso EC. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology. 2010;117(12):2241–6. https://doi.org/10.1016/j.ophtha.2010.03.052.

    Article  PubMed  Google Scholar 

  18. 18.

    Galor A, Karp CL, Chhabra S, Barnes S, Alfonso EC. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Br J Ophthalmol. 2010;94(5):551–4. https://doi.org/10.1136/bjo.2008.153197.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Muñoz de Escalona Rojas JE, García Serrano JL, Cantero Hinojosa J, Padilla Torres JF, Bellido Muñoz RM. Application of interferon alpha 2b in conjunctival intraepithelial neoplasia: predictors and prognostic factors. J Ocul Pharmacol Ther. 2014;30(6):489–94. https://doi.org/10.1089/jop.2013.0084.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Shields CL, Kaliki S, Kim HJ, et al. Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification. Cornea. 2013;32(3):248–56. https://doi.org/10.1097/ICO.0b013e3182523f61.

    Article  PubMed  Google Scholar 

  21. 21.

    Parrozzani R, Frizziero L, Trainiti S, et al. Topical 1% 5-fluoruracil as a sole treatment of corneoconjunctival ocular surface squamous neoplasia: long-term study. Br J Ophthalmol. 2017;101(8):1094–9. https://doi.org/10.1136/bjophthalmol-2016-309219.

    Article  PubMed  Google Scholar 

  22. 22.

    Joag MG, Sise A, Murillo JC, et al. Topical 5-fluorouracil 1% as primary treatment for ocular surface squamous neoplasia. Ophthalmology. 2016;123(7):1442–8. https://doi.org/10.1016/j.ophtha.2016.02.034.

    Article  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol. 2002;133(5):601–6.

    CAS  Article  Google Scholar 

  24. 24.

    Russell HC, Chadha V, Lockington D, Kemp EG. Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications. Br J Ophthalmol. 2010;94(10):1316–21. https://doi.org/10.1136/bjo.2009.176099.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Daniell M, Maini R, Tole D. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia. Clin Experiment Ophthalmol. 2002;30(2):94–8.

    Article  Google Scholar 

  26. 26.

    Ballalai PL, Erwenne CM, Martins MC, Lowen MS, Barros JN. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia. Ophthal Plast Reconstr Surg. 2009;25(4):296–9. https://doi.org/10.1097/iop.0b013e3181ac4c39.

    Article  PubMed  Google Scholar 

  27. 27.

    Gupta A, Muecke J. Treatment of ocular surface squamous neoplasia with mitomycin C. Br J Ophthalmol. 2010;94(5):555–8. https://doi.org/10.1136/bjo.2009.168294.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Besley J, Pappalardo J, Lee GA, Hirst LW, Vincent SJ. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b. Am J Ophthalmol. 2014;157(2):287–293.e2. https://doi.org/10.1016/j.ajo.2013.10.012.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    Shields JA, Shields CL, De Potter P. Surgical management of conjunctival tumors. The 1994 Lynn B McMahan Lecture. Arch Ophthalmol. 1997;115(6):808–15.

    CAS  Article  Google Scholar 

  30. 30.

    Adler E, Turner JR, Stone DU. Ocular surface squamous neoplasia: a survey of changes in the standard of care from 2003 to 2012. Cornea. 2013;32(12):1558–61. https://doi.org/10.1097/ICO.0b013e3182a6ea6c.

    Article  PubMed  Google Scholar 

  31. 31.

    Siedlecki AN, Tapp S, Tosteson ANA, et al. Surgery versus interferon alpha-2b treatment strategies for ocular surface squamous neoplasia: a literature-based decision analysis. Cornea. 2016;35(5):613–8. https://doi.org/10.1097/ICO.0000000000000766.

    Article  PubMed  PubMed Central  Google Scholar 

  32. 32.

    Basti S, Macsai MS. Ocular surface squamous neoplasia: a review. Cornea. 2003;22(7):687–704.

    Article  Google Scholar 

  33. 33.

    Kao AA, Galor A, Karp CL, Abdelaziz A, Feuer WJ, Dubovy SR. Clinicopathologic correlation of ocular surface squamous neoplasms at Bascom Palmer Eye Institute: 2001 to 2010. Ophthalmology. 2012;119(9):1773–6. https://doi.org/10.1016/j.ophtha.2012.02.049.

    Article  PubMed  Google Scholar 

  34. 34.

    Tole DM, McKelvie PA, Daniell M. Reliability of impression cytology for the diagnosis of ocular surface squamous neoplasia employing the Biopore membrane. Br J Ophthalmol. 2001;85(2):154–8. https://doi.org/10.1136/bjo.85.2.154.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  35. 35.

    Nolan GR, Hirst LW, Bancroft BJ. The cytomorphology of ocular surface squamous neoplasia by using impression cytology. Cancer. 2001;93(1):60–7.

    CAS  Article  Google Scholar 

  36. 36.

    Kieval JZ, Karp CL, Abou Shousha M, et al. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia. Ophthalmology. 2012;119(3):481–6. https://doi.org/10.1016/j.ophtha.2011.08.028.

    Article  PubMed  Google Scholar 

  37. 37.

    Thomas BJ, Galor A, Nanji AA, et al. Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia. Ocul Surf. 2014;12(1):46–58. https://doi.org/10.1016/j.jtos.2013.11.001.

    Article  PubMed  Google Scholar 

  38. 38.

    Parrozzani R, Lazzarini D, Dario A, Midena E. In vivo confocal microscopy of ocular surface squamous neoplasia. Eye Lond Engl. 2011;25(4):455–60. https://doi.org/10.1038/eye.2011.11.

    CAS  Article  Google Scholar 

  39. 39.

    Cohen BH, Green WR, Iliff NT, Taxy JB, Schwab LT, de la Cruz Z. Spindle cell carcinoma of the conjunctiva. Arch Ophthalmol. 1980;98(10):1809–13. https://doi.org/10.1001/archopht.1980.01020040661014.

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Rao NA, Font RL. Mucoepidermoid carcinoma of the conjunctiva: a clinicopathologic study of five cases. Cancer. 1976;38(4):1699–709. https://doi.org/10.1002/1097-0142(197610)38:4%3c1699:aid-cncr2820380443%3e3.0.co;2-4.

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    Rudkin AK, Dodd T, Muecke JS. The differential diagnosis of localised amelanotic limbal lesions: a review of 162 consecutive excisions. Br J Ophthalmol. 2011;95(3):350–4. https://doi.org/10.1136/bjo.2009.172189.

    Article  PubMed  Google Scholar 

  42. 42.

    Gallo B, Thuang C, Arora A, Cohen VML, Damato B, Sagoo MS. Invasive conjunctival malignant melanoma mimicking ocular surface squamous neoplasia: a case series. Paper presented at the OOG Spring Meeting; London; 11–13 Apr 2019.

  43. 43.

    Cervantes G, Rodríguez AA, Leal AG. Squamous cell carcinoma of the conjunctiva: clinicopathological features in 287 cases. Can J Ophthalmol. 2002;37(1):14–9 (discussion 19–20).

    Article  Google Scholar 

  44. 44.

    Tunc M, Char D, Crawford B, Miller T. Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases. Br J Ophthalmol. 1999;83(1):98–103.

    CAS  Article  Google Scholar 

  45. 45.

    Yousef YA, Finger PT. Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases. Ophthalmology. 2012;119(2):233–40. https://doi.org/10.1016/j.ophtha.2011.08.005.

    Article  PubMed  Google Scholar 

  46. 46.

    Tabbara KF, Kersten R, Daouk N, Blodi FC. Metastatic squamous cell carcinoma of the conjunctiva. Ophthalmology. 1988;95(3):318–21.

    CAS  Article  Google Scholar 

  47. 47.

    McKelvie PA, Daniell M, McNab A, Loughnan M, Santamaria JD. Squamous cell carcinoma of the conjunctiva: a series of 26 cases. Br J Ophthalmol. 2002;86(2):168–73. https://doi.org/10.1136/bjo.86.2.168.

    Article  PubMed  PubMed Central  Google Scholar 

  48. 48.

    Abt NB, Zhao J, Huang Y, Eghrari AO. Prognostic factors and survival for malignant conjunctival melanoma and squamous cell carcinoma over four decades. Am J Otolaryngol. 2019;40(4):577–82. https://doi.org/10.1016/j.amjoto.2019.05.013.

    Article  PubMed  Google Scholar 

  49. 49.

    Missotten GS, Keijser S, De Keizer RJW, De Wolff-Rouendaal D. Conjunctival melanoma in the Netherlands: a nationwide study. Invest Ophthalmol Vis Sci. 2005;46(1):75–82. https://doi.org/10.1167/iovs.04-0344.

    Article  PubMed  Google Scholar 

  50. 50.

    Bellerive C, Berry JL, Polski A, Singh AD. Conjunctival squamous neoplasia: staging and initial treatment. Cornea. 2018;37(10):1287–91. https://doi.org/10.1097/ICO.0000000000001651.

    Article  PubMed  PubMed Central  Google Scholar 

  51. 51.

    Santoni A, Thariat J, Maschi C, et al. Management of invasive squamous cell carcinomas of the conjunctiva. Am J Ophthalmol. 2019;200:1–9. https://doi.org/10.1016/j.ajo.2018.11.024.

    CAS  Article  PubMed  Google Scholar 

  52. 52.

    Arepalli S, Kaliki S, Shields CL, Emrich J, Komarnicky L, Shields JA. Plaque radiotherapy in the management of scleral-invasive conjunctival squamous cell carcinoma: an analysis of 15 eyes. JAMA Ophthalmol. 2014;132(6):691–6. https://doi.org/10.1001/jamaophthalmol.2014.86.

    Article  PubMed  Google Scholar 

  53. 53.

    Laskar S, Gurram L, Laskar SG, Chaudhari S, Khanna N, Upreti R. Superficial ocular malignancies treated with strontium-90 brachytherapy: long term outcomes. J Contemp Brachytherapy. 2015;7(5):369–73. https://doi.org/10.5114/jcb.2014.55003.

    Article  PubMed  PubMed Central  Google Scholar 

  54. 54.

    Kenawy N, Garrick A, Heimann H, Coupland SE, Damato BE. Conjunctival squamous cell neoplasia: the Liverpool Ocular Oncology Centre experience. Graefes Arch Clin Exp Ophthalmol. 2015;253(1):143–50. https://doi.org/10.1007/s00417-014-2860-7.

    CAS  Article  PubMed  Google Scholar 

  55. 55.

    Lecuona K, Stannard C, Hart G, et al. The treatment of carcinoma in situ and squamous cell carcinoma of the conjunctiva with fractionated strontium-90 radiation in a population with a high prevalence of HIV. Br J Ophthalmol. 2015;99(9):1158–61. https://doi.org/10.1136/bjophthalmol-2014-306327.

    Article  PubMed  Google Scholar 

  56. 56.

    Walsh-Conway N, Conway RM. Plaque brachytherapy for the management of ocular surface malignancies with corneoscleral invasion. Clin Experiment Ophthalmol. 2009;37(6):577–83. https://doi.org/10.1111/j.1442-9071.2009.02092.x.

    Article  PubMed  Google Scholar 

  57. 57.

    Graue GF, Tena LB, Finger PT. Electron beam radiation for conjunctival squamous carcinoma. Ophthal Plast Reconstr Surg. 2011;27(4):277–81. https://doi.org/10.1097/IOP.0b013e31820d872f.

    Article  PubMed  Google Scholar 

  58. 58.

    Moon CS, Nanji AA, Galor A, McCollister KE, Karp CL. Surgical versus medical treatment of ocular surface squamous neoplasia: a cost comparison. Ophthalmology. 2016;123(3):497–504. https://doi.org/10.1016/j.ophtha.2015.10.043.

    Article  PubMed  Google Scholar 

  59. 59.

    Mercado CL, Pole C, Wong J, et al. Surgical versus medical treatment for ocular surface squamous neoplasia: a quality of life comparison. Ocul Surf. 2019;17(1):60–3. https://doi.org/10.1016/j.jtos.2018.09.001.

    Article  PubMed  Google Scholar 

  60. 60.

    Baron S, Tyring SK, Fleischmann WR, et al. The interferons. Mechanisms of action and clinical applications. JAMA. 1991;266(10):1375–83.

    CAS  Article  Google Scholar 

  61. 61.

    Karp CL, Moore JK, Rosa RH. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology. 2001;108(6):1093–8. https://doi.org/10.1016/s0161-6420(01)00577-2.

    CAS  Article  PubMed  Google Scholar 

  62. 62.

    Schechter BA, Schrier A, Nagler RS, Smith EF, Velasquez GE. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea. 2002;21(1):6–11.

    Article  Google Scholar 

  63. 63.

    Abraham LM, Selva D, Casson R, Leibovitch I. The clinical applications of fluorouracil in ophthalmic practice. Drugs. 2007;67(2):237–55. https://doi.org/10.2165/00003495-200767020-00005.

    CAS  Article  PubMed  Google Scholar 

  64. 64.

    Rudkin AK, Dempster L, Muecke JS. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy. Clin Experiment Ophthalmol. 2015;43(1):20–5. https://doi.org/10.1111/ceo.12377.

    Article  PubMed  Google Scholar 

  65. 65.

    Rudkin AK, Muecke JS. Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia. Br J Ophthalmol. 2011;95(7):947–50. https://doi.org/10.1136/bjo.2010.186171.

    Article  PubMed  Google Scholar 

  66. 66.

    Abraham LM, Selva D, Casson R, Leibovitch I. Mitomycin: clinical applications in ophthalmic practice. Drugs. 2006;66(3):321–40. https://doi.org/10.2165/00003495-200666030-00005.

    CAS  Article  PubMed  Google Scholar 

  67. 67.

    Ditta LC, Shildkrot Y, Wilson MW. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences. Ophthalmology. 2011;118(9):1754–9. https://doi.org/10.1016/j.ophtha.2011.01.060.

    Article  PubMed  Google Scholar 

  68. 68.

    Khong JJ, Muecke J. Complications of mitomycin C therapy in 100 eyes with ocular surface neoplasia. Br J Ophthalmol. 2006;90(7):819–22. https://doi.org/10.1136/bjo.2005.086850.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  69. 69.

    Kim HJ, Shields CL, Shah SU, Kaliki S, Lally SE. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction. Ophthalmology. 2012;119(5):938–44. https://doi.org/10.1016/j.ophtha.2011.11.035.

    Article  PubMed  Google Scholar 

  70. 70.

    Mittal V, Narang P, Menon V, Mittal R, Honavar S. Primary simple limbal epithelial transplantation along with excisional biopsy in the management of extensive ocular surface squamous neoplasia. Cornea. 2016;35(12):1650–2. https://doi.org/10.1097/ICO.0000000000000953.

    Article  PubMed  Google Scholar 

  71. 71.

    Kaliki S, Mohammad FA, Tahiliani P, Sangwan VS. Concomitant simple limbal epithelial transplantation after surgical excision of ocular surface squamous neoplasia. Am J Ophthalmol. 2017;174:68–75. https://doi.org/10.1016/j.ajo.2016.10.021.

    Article  PubMed  Google Scholar 

  72. 72.

    Shields CL, Demirci H, Marr BP, Masheyekhi A, Materin M, Shields JA. Chemoreduction with topical mitomycin C prior to resection of extensive squamous cell carcinoma of the conjunctiva. Arch Ophthalmol. 2005;123(1):109–13. https://doi.org/10.1001/archopht.123.1.109.

    Article  PubMed  Google Scholar 

  73. 73.

    Murillo JC, Galor A, Wu MC, et al. Intracorneal and intraocular invasion of ocular surface squamous neoplasia after intraocular surgery: report of two cases and review of the literature. Ocul Oncol Pathol. 2017;3(1):66–72. https://doi.org/10.1159/000450752.

    Article  PubMed  Google Scholar 

  74. 74.

    Conway RM, Graue GF, Pelayes D. Conjunctival carcinoma. American Joint Committee on Cancer (AJCC) AJCC Cancer Staging Manual 8th Ed. New York: Springer; 2017.

  75. 75.

    Singh S, Mohamed A, Kaliki S. Ocular surface squamous neoplasia: analysis based on the 8th American Joint Committee on Cancer classification. Int Ophthalmol. 2019;39(6):1283–91. https://doi.org/10.1007/s10792-018-0943-x.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Funding

No funding or sponsorship was received for this study or publication of this article.

Authorship

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Disclosures

Victoria Cohen and Roderick O’Day have nothing to disclose.

Compliance with Ethics Guidelines

This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Victoria M. L. Cohen.

Additional information

Enhanced Digital Features

To view enhanced digital features for this article go to https://doi.org/10.6084/m9.figshare.10298465.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cohen, V.M.L., O’Day, R.F. Management Issues in Conjunctival Tumours: Ocular Surface Squamous Neoplasia. Ophthalmol Ther 9, 181–190 (2020). https://doi.org/10.1007/s40123-019-00225-w

Download citation

Keywords

  • 5-Fluorouracil
  • Conjunctival intraepithelial neoplasia
  • Interferon-α2b
  • Mitomycin C
  • Ocular surface squamous neoplasia
  • Squamous cell carcinoma of the conjunctiva